Barbara Arone

Webinar: Balancing Innovation, Ethics, and Operational Excellence in Adaptive Oncology Trials Clinical trials are evolving to incorporate adaptive designs, offering flexibility to refine protocols based on emerging data. Join us as leading experts in cancer research come together to discuss how to navigate the complexities of adaptive trials designs and how ethics reviews uphold patient safety, ensure informed consent, and provide robust oversight for evolving trial designs.

Why Sponsors Should Obsess Over Clinical Trial Oversight Just in Time GCP Founder and CEO Donna Dorozinsky explores the importance of clinical trial oversight and what to expect for the future of clinical trial oversight. Optimizing CAGT Post-Trial Long-Term Follow-Up Uncover how navigating longer study durations presents unique challenges, necessitating efficient data collection methods and flexibility to adapt to evolving patient journeys and regulatory landscapes.

Barbara Arone, vice president, real world solutions, IQVIA, examines the ways biotech and emerging biopharma companies can effectively apply real world evidence (RWE) early in the product lifecycle while staying within their resource limits. Key insights: With the rise in precision medicine, RWE is a 'must have' that helps to contextualise clinical research and aid in the understanding of treatments being developed.